S7, Ep 5- How ACIP Lawsuits are Impacting Patients: When Vaccine Guidance Becomes an Access Problem
About this episode
The episode discusses the impact of ACIP lawsuits on patient access to vaccines and the connection between ACIP recommendations and real-world vaccination systems.
In this episode of Healthcare Matters, Dr. Robert Popovian and co-host Angela Degrassi discuss why uncertainty surrounding the CDC’s Advisory Committee on Immunization Practices, known as ACIP, matters far beyond Washington, DC. The conversation explains how ACIP recommendations are connected to the real-world systems that help patients get vaccinated, including pharmacist authority, state scope-of-practice laws, and Medicaid reimbursement. Dr. Popovian explains that adult vaccination is especially vulnerable to disruption because most adults receive vaccines at pharmacies, and in many states, pharmacists’ ability to administer vaccines is tied to ACIP recommendations. The episode also explores why seasonal vaccines, such as flu and COVID vaccines, are particularly exposed to uncertainty because they require updated authorization and recommendations each year. Robert and Angela discuss what happened when COVID vaccine guidance was delayed, how some states responded with temporary workarounds, and why not every state may be prepared to act quickly if similar uncertainty continues. The discussion also highlights GHLF’s new integration of Walgreens’ Vaccine…
Topics covered
- vaccine access
- ACIP recommendations
- pharmacy vaccination
- adult vaccination
- COVID vaccine guidance
- healthcare policy
Keywords
- ACIP
- vaccination
- pharmacists
- Medicaid reimbursement
- COVID vaccines
- seasonal vaccines
- vaccine hub
- Walgreens Vaccine Scheduler
More episodes of Healthcare Matters
- S7, Ep 6- 340B Program & Hospital Charity Care: What Patients Need to Know
- S7, Ep 4- COVID Antivirals: Are High-Risk Patients Missing the Window?
- S7, Ep 3- 340B: Are Patients Seeing the Savings?
- S7, Ep 2- PBM Reform at an Inflection Point: What Comes Next?
- S7, Ep 1- The $29 Billion Problem: Understanding Influenza's True Economic Toll
- S6, Ep 10- TrumpRx & the Future of Drug Pricing: What Patients Need to Know
Explore listener stats, chart rankings, contacts and more on the Healthcare Matters podcast page.